Compare Erasca Inc. Common Stock (ERAS) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Erasca Inc. Common Stock vs Immunovant Inc. Common Stock — how do they compare? Erasca Inc. Common Stock trades at $15.57 (market cap $4.95B), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: Immunovant Inc. Common Stock is the larger of the two by market cap, and Erasca Inc. Common Stock is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Erasca Inc. Common Stock for 0 Days and Immunovant Inc. Common Stock for 0 Days on average.
| ERAS | IMVT | |
|---|---|---|
Market Cap | $4.95B | $6.62B |
Volume | 3,834,689 | 1,131,364 |
Sector | Health | Health |
52-Week High | $22.47 | $44.96 |
52-Week Low | $2.20 | $17.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.72B | $5.72B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Erasca Inc. Common Stock
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
